___

• 1. Sun Z. Atherosclerosis and atheroma plaque rupture: normal anatomy of vasa vasorum and their role. Scientific World Journal 2014; 2014: 285058.
• 2. Matsuura E, Kobayashi K, Tabuchi M, Lopez LR. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res 2006; 45: 466–486.
• 3. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006; 47: C7–12.
• 4. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233–241.
• 5. Rizzo M, Berneis K. Should we measure routinely the LDL peak particle size? Int J Cardiol 2006; 107: 166–170.
• 6. Tsimihodimos V, Gazi I, Kostara C, Tselepis AD, Elisaf M. Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particles. Lipids 2007; 42: 403–409.
• 7. Björnheden T, Babyi A, Bondjers G, Wiklund O. Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis 1996; 123: 43–56.
• 8. Galeano NF, Al-Haideri M, Keyserman F, Rumsey SC, Deckelbaum RJ. Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity. J Lipid Res 1998; 39: 1263–1273.
• 9. Yoshida A, Kouwaki M, Matsutani Y, Fukuchi Y, Naito M. Usefulness of serum total cholesterol/triglyceride ratio for predicting the presence of small, dense LDL. J Atheroscler Thromb 2004; 11: 215–219.
• 10. Liu ML, Ylitalo K, Nuotio I, Salonen R, Salonen JT, Taskinen M-R. Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families. Stroke 2002; 33: 1255– 1260.
• 11. National Cholesterol Education Program. Report of the expert panel on population strategies for blood cholesterol reduction: Executive summary. Arch Intern Med 1991; 151: 1071–1084.
• 12. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol 1986; 128: 417–431.
• 13. Arisaka O, Fujiwara S, Yabuta K, Mokuno H, Mitugi Y, Miyake N. Characterization of low-density lipoprotein subclasses in children. Metabolism 1997; 46: 146–148.
• 14. Hirano T, Ito Y, Saegusa H, Yoshino G. A novel and simple method for quantification of small, dense LDL. J Lipid Res 2003; 44: 2193–2201.
• 15. Arisaka O, Kojima M, Yamazaki Y, Kanazawa S, Koyama S, Shimura N, Okada T. Relationship between the presence of small, dense low-density lipoprotein and plasma lipid phenotypes in Japanese children. J Atheroscler Thromb 2004; 11: 220–223.
• 16. Pauciullo P, Gentile M, Marotta G, Baiano A, Ubaldi S, Jossa F, Iannuzzo G, Faccenda F, Panico S, Rubba P. Small dense low-density lipoprotein in familial combined hyperlipidemia: independent of metabolic syndrome and related to history of cardiovascular events. Atherosclerosis 2009; 203: 320–324.
• 17. Rizzo M, Perez-Martinez P, Nikolic D, Montalto G, LopezMiranda J. Emerging approaches for the treatment of hypertriglyceridemia. Expert Opin Pharmacother 2013; 14: 1869–1873.
• 18. Packard CJ, Shepherd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 1997; 17: 3542–3556.
• 19. Berneis KK. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002; 43: 1363–1379.
• 20. Sacks FM, Campos H. Clinical review 163: Cardiovascular endocrinology: Low-density lipoprotein size and cardiovascular disease: a reappraisal. J Clin Endocrinol Metab 2003; 88: 4525–4532.
• 21. Rizzo M, Berneis K. Who needs to care about small, dense lowdensity lipoproteins? Int J Clin Pract 2007; 61: 1949–1956.
• 22. Nishikura T, Koba S, Yokota Y, Hirano T, Tsunoda F, Shoji M, Hamazaki Y, Suzuki H, Itoh Y, Katagiri T et al. Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease. J Atheroscler Thromb 2014; 21: 755–767.
• 23. St-Pierre AC, Cantin B, Dagenais GR, Mauriège P, Bernard PM, Després JP, Lamarche B. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13- year follow-up data from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol 2005; 25: 553–559.
• 24. Tani S, Matsumoto M, Nagao K, Hirayama A. Association of triglyceride-rich lipoproteins-related markers and lowdensity lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size. J Cardiol 2014; 63: 60–68.
• 25. Talayero B, Sacks F. The role of triglycerides in atherosclerosis. Curr Cardiol Rep 2011; 13: 544–552.
• 26. Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 2011; 32: 1345–1361.
• 27. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495–506.
• 28. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994; 106: 241– 253.
• 29. Rizzo M, Barbagallo CM, Severino M, Polizzi F, Onorato F, Noto D, Cefalù AB, Pace A, Marino G, Notarbartolo A et al. Low-density-lipoprotein peak particle size in a Mediterranean population. Eur J Clin Invest 2003; 33: 126–133.
• 30. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917–1921.
• 31. Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PW, Schaefer EJ. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb Vasc Biol 1992; 12: 187–195.
• 32. Er Öztaş Y, Özdöl C, Karaca L. Plasma LDL subtype distribution in patients with or without coronary stenosis. Turk J Med Sci 2011; 41: 959–964.
• 33. Maruyama C, Imamura K, Teramoto T. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in nondiabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb 2003; 10: 186–191.
• 34. Skoglund-Andersson C, Tang R, Bond MG, de Faire U, Hamsten A., Karpe F. LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men. Arterioscler Thromb Vasc Biol 1999; 19: 2422–2430.
• 35. Williams PT, Vranizan KM, Krauss RM. Correlations of plasma lipoproteins with LDL subfractions by particle size in men and women. J Lipid Res 1992; 33: 765–774.
• 36. King RI, Florkowski CM, Yeo J, Walmsley TA, Shand BI, Scott RS, George PM. What is the best predictor of the atherogenic LDL subclass phenotype “pattern B” in patients with type 2 diabetes mellitus? Ann Clin Biochem 2011; 48: 166–169.
• 37. Zeljkovic A, Vekic J, Spasojevic-Kalimanovska V, Jelic-Ivanovic Z, Peco-Antic A, Kostic M, Vasic D, Spasic S. Characteristics of low-density and high-density lipoprotein subclasses in pediatric renal transplant recipients. Transpl Int 2011; 24: 1094–1102.
• 38. Hirano T, Ito Y, Koba S, Toyoda M, Ikejiri A, Saegusa H, Yamazaki J, Yoshino G. Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler Thromb Vasc Biol 2004; 24: 558–563.
• 39. Singer R. Serum LDL-C tayininde iki direkt yöntem ile Friedewald formülü karşılaştırılması ve küçük, yoğun LDL-C ölçüm yöntemi. İstanbul, Turkey: Haydarpaşa Paragon Hospital; 2006 (in Turkish).
• 40. Hirano T, Ito Y, Yoshino G. Measurement of small dense lowdensity lipoprotein particles. J Atheroscler Thromb 2005; 12: 67–72.